Autori: Papanas Nikolaos
| Naslov | The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better! (Editorial Material; Early Access) |
| Autori | Popovic Djordje S  Koufakis Theocharis Papanas Nikolaos
|
| Info | CURRENT VASCULAR PHARMACOLOGY, (2023), vol. br. , str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
     |
| Naslov | Should tirzepatide be considered for early management in type 2 diabetes? Pros and cons (Editorial Material; Early Access) |
| Autori | Koufakis Theocharis Popovic Djordje S Papanas Nikolaos
|
| Info | EXPERT OPINION ON PHARMACOTHERAPY, (2023), vol. br. , str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
|
| Naslov | Contrast-Associated Acute Kidney Injury: More Frequent Among Patients With Diabetic Foot Ulcers (Editorial Material; Early Access) |
| Autori | Popovic Djordje S Papanas Nikolaos
|
| Info | ANGIOLOGY, (2023), vol. br. , str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
|
| Naslov | Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk (Letter; Early Access) |
| Autori | Papachristou Stella Popovic Djordje S Papanas Nikolaos
|
| Info | INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, (2023), vol. br. , str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
|
| Naslov | Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus? (Letter; Early Access) |
| Autori | Popovic Djordje S Stoian Anca Pantea Papanas Nikolaos
|
| Info | ENDOCRINE, (2023), vol. br. , str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Post COVID-19 syndrome related to diabetes - A brief review (Review) |
| Autori | Stoian Anca Pantea Rizzo M Salmen T Kempler Peter Stulnig T Papanas Nikolaos Popovic Djordje S Herder C Serban D
|
| Info | DIABETES STOFFWECHSEL UND HERZ, (2022), vol. 31 br. 2, str. 126-130 |
| Ispravka | Web of Science Elečas Rang časopisa |
|
|
| Naslov | Could cardiorenal benefits of sodium-glucose co-transporter 2 inhibitors be extended to type 1 diabetes mellitus? (Letter) |
| Autori | Popovic Djordje S Stoian Anca Pantea Papanas Nikolaos
|
| Info | JOURNAL OF DIABETES AND ITS COMPLICATIONS, (2022), vol. 36 br. 11, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Ezetimibe and Insulin Resistance (Editorial Material) |
| Autori | Popovic Djordje S Papachristou Stella Stokic Edita J Papanas Nikolaos
|
| Info | CURRENT VASCULAR PHARMACOLOGY, (2022), vol. 20 br. 4, str. 315-317 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Achieving LDL-cholesterol Targets: How Good are we in the Balkan Region? (Editorial Material) |
| Autori | Popovic Djordje S Stokic Edita J Stoian Anca Pantea Papanas Nikolaos
|
| Info | CURRENT VASCULAR PHARMACOLOGY, (2022), vol. 20 br. 4, str. 311-312 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention (Editorial Material) |
| Autori | Popovic Djordje S Koufakis Theocharis Kovacevic Bojan Rizzo Manfredi Papanas Nikolaos
|
| Info | EXPERT OPINION ON DRUG SAFETY, (2022), vol. 21 br. 11, str. 1337-1339 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
